TABLE VI.
Characteristics | Univariable associations | Final multivariable model | ||
---|---|---|---|---|
Median (IQR) | P value | Unstandardized β coefficient (95% CI) | P value | |
Sex* | <.001 | |||
Female | 50.0 (43.5–56.0) | −2.4 (−3.5 to −1.3) | <.001 | |
Male | 53.9 (49.3–57.4) | Reference | ||
Age (y)* | .447 | |||
<35 | 52.1 (46.8–57.3) | |||
35–45 | 52.1 (47.1–57.5) | |||
≥45 | 51.0 (43.0–57.5) | |||
Smoking habit* | .248 | |||
Never smoked | 52.1 (47.0–57.5) | |||
Ex-smoker | 52.4 (46.1–57.5) | |||
Current smoker | 51.3 (44.8–57.3) | |||
Body mass index (kg/m2)* | .279 | |||
<25 | 52.3 (46.9–57.5) | |||
≥25 | 51.3 (45.0–57.4) | |||
Education level* | .458 | |||
>12 y | 51.5 (46.7–57.3) | |||
≤12 y | 52.0 (46.3–57.5) | |||
Current job duration* | .047 | |||
<5 y | 52.3 (48.1–57.5) | |||
≥5 y | 51.4 (45.2–57.4) | |||
Asthma preexisting to current job | ||||
Yes | 49.4 (42.1–54.8) | .505 | ||
No | 49.6 (39.0–54.6) | |||
Asthma control | .016 | |||
ACT score > 19 | 49.9 (42.9–55.0) | |||
ACT score ≤ 19 | 46.1 (40.3–51.6) | |||
Asthma* | <.001 | |||
Absent | 52.4 (48.2–57.5) | Reference | ||
Non-WRA | 50.7 (43.9–56.3) | −2.1 (−3.7 to −0.5) | .009 | |
WRA† | 45.7 (36.6–52.4) | −4.6 (−6.5 to −2.7) | <.001 | |
Depression, physician-based | <.001 | |||
Absent | 52.3 (48.1–57.5) | Reference | ||
Present | 43.7 (37.1–52.3) | −7.6 (−9.3 to −5.8) | <.001 | |
Nonrespiratory, nondepression comorbidity | .006 | |||
Absent | 52.5 (46.8–57.5) | Reference | ||
Present | 50.8 (45.6–56.6) | −2.1 (−3.3 to −0.9) | <.001 |
IQR, Interquartile range.
Multivariable analysis was done on 822 subjects and incorporated well-known confounders such as age, sex, smoking habits, body mass index, academic level, and current job duration (marked with asterisks) and other covariates with a P value of <.1 in univariable analyses. Asthma control was not included because the information was available only among asthmatic subjects.
Well-known confounders included in the multivariable analysis.
WRA is defined as current asthma associated with ≥2 WRA symptoms.